Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

Konference: 2014 56th ASH Annual Meeting - účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: 642. CLL: Therapy, excluding Transplantation: Phase 3 Trials and More

Číslo abstraktu: 19

Autoři: MD Barbara Eichhorst; MD Anna-Maria Fink; Dipl.Math. Raymonde Busch, Ph.D.; Gabor Kovacs; Christian Maurer; M.D. Elisabeth Lange; Prof. Dr. Hubert Köppler; M.D. Michael Kiehl; M.D. Martin Soekler (Sökler); MD Rudolf Schlag; MD Ursula Vehling-Kaiser; M.D. Georg Köchling (Koechling); M.D. Christoph Plöger (Ploeger); M.D. Michael Gregor; MD Torben Plesner; Prof. MUDr. Marek Trněný, CSc.; M.D. Kirsten Fischer; Prof. Dr. med. Hartmut Döhner (Doehner); MD Michael Kneba, PhD; MD Clement Martin Wendtner; MD Wolfram Klapper, PhD; M.D. Karl-Anton Kreuzer; MD Stephan Stilgenbauer; MD Sebastian Böttcher; Prof. MD Michael Hallek

Datum přednesení příspěvku: 6. 12. 2014